Showing results (481-490 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patientsMark E Dudley, John R Wunderlich, Thomas E Shelton, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the peripheryShoko Tanaka, Mamoru Harada, Takashi Mine, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 5, 2021
Preclinical Evaluation of CD64 As a Potential Target For CAR-T-cell Therapy For Acute Myeloid LeukemiaXiaolei Sun, Guoling Wang, Shiyu Zuo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 19, 2019
Clinical Correlates of Response to Anti-PD-1-based Therapy in Patients With Metastatic MelanomaElizabeth J Davis, Matthew C Perez, Noura Ayoubi, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2019
UV Light-inactivated HSV-1 Stimulates Natural Killer Cell-induced Killing of Prostate Cancer CellsIsmael Samudio, Elyse Hofs, Brandon Cho, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2019
Association of Insurance Status With Presentation, Treatment, and Survival in Melanoma in the Era of Immune Checkpoint InhibitorsVarsha Jain, Sriram Venigalla, Vishruth K Reddy, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2019
Immune-related Neutropenia Following Treatment With Immune Checkpoint InhibitorsInbar Finkel, Michal Sternschuss, Mira Wollner, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 1, 2019
Severe Acute Kidney Injury Due to Nivolumab/Ipilimumab-induced Granulomatosis and Fibrinoid Vascular NecrosisFermin Person, Tuhama Chahoud-Schriefer, Wilfrid Fehrle, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 1, 2019
Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor TherapyDavid J Pinato, Heather Urus, Thomas Newsom-Davis, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 2, 2019
Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-AnalysisFausto Petrelli, Giulia Grizzi, Michele Ghidini, et al.Pageof 176